Ultivue Announces $50M Financing Round
CAMBRIDGE, Mass., April 28 (Bernama-BUSINESS WIRE) — Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue phenotyping, today announced the completion of a $50 million Series D round of financing. New investors include Ally Bridge Group, Pura…

